Scarica l'app Stockscreener
1.44
4.00%
-0.06
Dopo l'orario di chiusura:
1.43
-0.01
-0.69%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ZNTL Giù?
Forum
Previsione
Precedente Chiudi:
$1.50
Aprire:
$1.49
Volume 24 ore:
624.92K
Relative Volume:
0.85
Capitalizzazione di mercato:
$103.88M
Reddito:
-
Utile/perdita netta:
$-292.19M
Rapporto P/E:
-0.3172
EPS:
-4.54
Flusso di cassa netto:
$-208.41M
1 W Prestazione:
-16.28%
1M Prestazione:
-10.56%
6M Prestazione:
-0.69%
1 anno Prestazione:
-56.63%
Intervallo 1D:
$1.43
$1.54
Intervallo di 1 settimana:
$1.43
$1.77
Portata 52W:
$1.01
$4.44
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
Nome
Zentalis Pharmaceuticals Inc
Settore
Industria
Telefono
(858) 263-4333
Indirizzo
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Confronta ZNTL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZNTL
Zentalis Pharmaceuticals Inc
|
1.44 | 108.20M | 0 | -292.19M | -208.41M | -4.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-12 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2024-06-20 | Downgrade | UBS | Buy → Neutral |
| 2024-06-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-18 | Downgrade | Wedbush | Neutral → Underperform |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-11-08 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2022-07-12 | Iniziato | Cowen | Outperform |
| 2022-04-06 | Iniziato | Wells Fargo | Overweight |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-09-30 | Iniziato | Stifel | Buy |
| 2021-09-29 | Iniziato | Oppenheimer | Outperform |
| 2021-05-21 | Iniziato | UBS | Buy |
| 2021-01-20 | Iniziato | Wedbush | Outperform |
| 2020-09-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-28 | Iniziato | Guggenheim | Buy |
| 2020-04-28 | Iniziato | Jefferies | Buy |
| 2020-04-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-04-28 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Zentalis Pharmaceuticals Inc Borsa (ZNTL) Ultime notizie
Why analysts upgrade Zentalis Pharmaceuticals Inc. stockJuly 2025 Fed Impact & Low Drawdown Investment Ideas - newser.com
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
Zentalis (NASDAQ: ZNTL) to participate in Guggenheim and Stifel healthcare conferences - Stock Titan
Relative strength of Zentalis Pharmaceuticals Inc. in sector analysis2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
Why Zentalis Pharmaceuticals Inc. stock is in analyst buy zoneWeekly Risk Summary & Daily Oversold Bounce Ideas - newser.com
Is Zentalis Pharmaceuticals Inc. stock in correction or buying zoneEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com
Can Zentalis Pharmaceuticals Inc. stock beat market expectations this quarterEarnings Recap Report & Low Risk Entry Point Tips - newser.com
Will Zentalis Pharmaceuticals Inc. stock keep outperforming rivals2025 Earnings Impact & AI Enhanced Trading Signals - newser.com
How currency fluctuations impact Zentalis Pharmaceuticals Inc. stockEarnings Growth Report & Smart Investment Allocation Tips - newser.com
Can Zentalis Pharmaceuticals Inc. rally from current levelsInflation Watch & Real-Time Chart Pattern Alerts - newser.com
Why Zentalis Pharmaceuticals Inc. stock remains undervaluedPortfolio Risk Report & AI Driven Price Predictions - newser.com
Can Zentalis Pharmaceuticals Inc. stock reach $100 price targetEarnings Miss & Community Driven Trade Alerts - newser.com
Is Zentalis Pharmaceuticals Inc. forming a bottoming baseEarnings Risk Summary & Technical Buy Zone Confirmation - newser.com
How Zentalis Pharmaceuticals Inc. stock benefits from strong dollarInsider Buying & Daily Entry Point Trade Alerts - newser.com
What analysts say about Zentalis Pharmaceuticals Inc stockVolume Analysis Techniques & Daily Tips From Top Market Analysts - earlytimes.in
Multi asset correlation models including Zentalis Pharmaceuticals Inc.2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
What recovery options are there for Zentalis Pharmaceuticals Inc.Profit Target & AI Forecast for Swing Trade Picks - newser.com
Zentalis Pharmaceuticals Stock Faces Pressure as Insider Bets Turn Negative - AD HOC NEWS
Zentalis Pharmaceuticals Slides As Insider Purchases Lose Another US$37k - simplywall.st
How to build a custom watchlist for Zentalis Pharmaceuticals Inc.2025 Price Targets & Verified Chart Pattern Trade Signals - newser.com
How Zentalis Pharmaceuticals Inc. stock performs in high volatility marketsStop Loss & Fast Gaining Stock Strategy Reports - newser.com
Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Zentalis Pharmaceuticals Inc Azioni (ZNTL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bruns Ingmar | Chief Medical Officer |
Feb 06 '25 |
Buy |
2.28 |
20,000 |
45,656 |
36,629 |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):